Berberine reduces circulating inflammatory mediators in patients with severe COVID-19.

Zhang, B Y; Chen, M; Chen, X C; Cao, K; You, Y; Qian, Y J; Yu, W K

Zhang, B Y; Chen, M; Chen, X C; Cao, K; You, Y; Qian, Y J; Yu, W K.

Zhang BY; Department of Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, Jiangsu Province 210008, China.
Chen M; Department of Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, Jiangsu Province 210008, China.
Chen XC; Department of Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, Jiangsu Province 210008, China.
Cao K; Department of Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, Jiangsu Province 210008, China.
You Y; Department of Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, Jiangsu Province 210008, China.
Qian YJ; Department of Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, Jiangsu Province 210008, China.
Yu WK; Department of Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, Jiangsu Province 210008, China.

Br J Surg ; 108(1): e9-e11, 2021 Jan 27.

Artículo en Inglés | MEDLINE | ID: covidwho-1901118

Asunto(s)

Antiinflamatorios/uso terapéutico; Antivirales/uso terapéutico; Berberina/uso terapéutico; Tratamiento Farmacológico de COVID-19; COVID-19/sangre; Mediadores de Inflamación/sangre; Síndrome de Liberación de Citoquinas/sangre; Síndrome de Liberación de Citoquinas/tratamiento farmacológico; Humanos; Estudios Prospectivos; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Antivirales / Berberina / Mediadores de Inflamación / COVID-19 / Tratamiento Farmacológico de COVID-19 / Antiinflamatorios Tipo de estudio: Estudio de cohorte / Estudio observacional / Estudio pronóstico Límite: Humanos Idioma: Inglés Revista: Br J Surg Año: 2021 Tipo del documento: Artículo País de afiliación: Bjs

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google